Open access
Sep 2026
Cost-utility analysis of erenumab preventive treatment for chronic migraine in China
Objective This study aimed to evaluate the cost-utility of erenumab preventive treatment compared to no preventive treatment in adults with chronic migraine in China. Methods An individual-level microsimulation model was developed from the perspective of the Chinese health system. The model compared erenumab 70 mg ever...
Li-Jiang Wang, Meng-Lu Zhu, Qing-Qing Hu et al.
· Frontiers in Public Health · 0 citations